Purmx Therapeutics is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.
Purmx Therapeutics's investors include Mitsubishi UFJ Capital, UTEC - The University of Tokyo Edge Capital Partners, Hiroshima Venture Capital, Osaka University Venture Capital, Keio Innovation Initiative.
Purmx Therapeutics is headquartered in Hiroshima, Japan.
Purmx Therapeutics is a pharmaceutical company that develops RNA nucleic acid medicine for therapeutic effects on intractable diseases.
Purmx Therapeutics is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Purmx Therapeutics — Funding & Investors." VCBacked, September 29, 2026, https://www.vcbacked.co/company/purmx-therapeutics. Accessed October 13, 2026.
VCBacked. (2026). Purmx Therapeutics — Funding & Investors. Retrieved October 13, 2026, from https://www.vcbacked.co/company/purmx-therapeutics
{{cite web |title=Purmx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/purmx-therapeutics |website=VCBacked |access-date=October 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated